Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Massimo Volpe

Showing results (111-120 of 820) with videos related to

Pageof 82
Sort By:
European Heart Journal|March 11, 2021
The value of sotagliflozin in patients with diabetes and heart failure detracted by an unexpected endingMassimo Volpe, Carlo Patrono
European Heart Journal|January 9, 2025
Weekly Journal Scan: the (BP)ROAD to optimal blood pressure control in type-2 diabetesDaniela Pedicino, Massimo Volpe
European Heart Journal|October 26, 2022
From the management of altitude sickness to treatment of congestion in acute heart failure: a new season for acetazolamide?Daniela Pedicino, Massimo Volpe
Current Hypertension Reports|February 3, 2005
Hypertension, stroke, and endotheliumFrancesco Cosentino, Massimo Volpe
Journal of Nephrology|December 6, 2007
Therapeutic implications of recent megatrials in hypertension: in favor of new drugsMassimo Volpe, Giuliano Tocci
Current Opinion in Nephrology and Hypertension|August 18, 2006
Antihypertensive therapy and cerebrovascular protectionMassimo Volpe, Giuliano Tocci
European Heart Journal|June 28, 2023
Artificial intelligence in echocardiography: a better alternative to the human eye?Leonarda Galiuto, Massimo Volpe
European Heart Journal|December 1, 2022
Protection and delay of aortic complications in the Marfan syndrome: a new indication for angiotensin receptor blockers on top of β blockersDaniela Pedicino, Massimo Volpe
European Heart Journal|April 29, 2025
Weekly Journal Scan: Effects of oral semaglutide on cardiovascular outcomes in patients with type 2 diabetes and high risk profileGiovanna Gallo, Massimo Volpe
European Heart Journal|December 9, 2022
A gender issue in the diagnostic imaging work-up of stable coronary artery disease? Insights from DISCHARGERocco Vergallo, Massimo Volpe
Pageof 82

Showing results (111-120 of 820) with videos related to

Sort By:
Pageof 82
European Heart Journal|March 11, 2021
The value of sotagliflozin in patients with diabetes and heart failure detracted by an unexpected endingMassimo Volpe, Carlo Patrono
European Heart Journal|January 9, 2025
Weekly Journal Scan: the (BP)ROAD to optimal blood pressure control in type-2 diabetesDaniela Pedicino, Massimo Volpe
European Heart Journal|October 26, 2022
From the management of altitude sickness to treatment of congestion in acute heart failure: a new season for acetazolamide?Daniela Pedicino, Massimo Volpe
Current Hypertension Reports|February 3, 2005
Hypertension, stroke, and endotheliumFrancesco Cosentino, Massimo Volpe
Journal of Nephrology|December 6, 2007
Therapeutic implications of recent megatrials in hypertension: in favor of new drugsMassimo Volpe, Giuliano Tocci
Current Opinion in Nephrology and Hypertension|August 18, 2006
Antihypertensive therapy and cerebrovascular protectionMassimo Volpe, Giuliano Tocci
European Heart Journal|June 28, 2023
Artificial intelligence in echocardiography: a better alternative to the human eye?Leonarda Galiuto, Massimo Volpe
European Heart Journal|December 1, 2022
Protection and delay of aortic complications in the Marfan syndrome: a new indication for angiotensin receptor blockers on top of β blockersDaniela Pedicino, Massimo Volpe
European Heart Journal|April 29, 2025
Weekly Journal Scan: Effects of oral semaglutide on cardiovascular outcomes in patients with type 2 diabetes and high risk profileGiovanna Gallo, Massimo Volpe
European Heart Journal|December 9, 2022
A gender issue in the diagnostic imaging work-up of stable coronary artery disease? Insights from DISCHARGERocco Vergallo, Massimo Volpe
Pageof 82